Stay updated on SL-401 in BPDCN or AML Clinical Trial
Sign up to get notified when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.

Latest updates to the SL-401 in BPDCN or AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record for tagraxofusp is displayed, including the study design, eligibility criteria, outcomes, locations, and supporting documents.SummaryDifference60%

- Check17 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH website transition updates and says that agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check30 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1; the study page continues to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedAccess to the study record page is returning a 403 Forbidden error. The page displays an error screen instead of the study content.SummaryDifference20%

Stay in the know with updates to SL-401 in BPDCN or AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SL-401 in BPDCN or AML Clinical Trial page.